Petřík Miloš Ph.D.
Journals
The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection.
Journal of Nuclear Medicine.
2023,
ISSN: 0161-5505,
PMID: 37770110.
[68Ga]Ga-Ornibactin for Burkholderia cepacia complex Infection Imaging Using Positron Emission Tomography.
Journal of Medicinal Chemistry.
2023,
ISSN: 0022-2623,
PMID: 37252893,
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin.
Theranostics.
2022,
12(17),
7203-7215,
ISSN: 1838-7640,
PMID: 36438496,
Bachelor mentorship
Open positions
Projekt: | Preclinical development of molecular imaging agents |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 2 |
Určeno pro: | Doktorské studium |
Projekt: | Preclinical development of substances for molecular imaging |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 1 |
Určeno pro: | Doktorské studium |
Souhrn: | 1 place in full-time study |
Projekt: | In vivo imaging of 68Ga labelled biomolecules |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 1 |
Určeno pro: | Bakalářské studium |
Projekt: | Radiolabelled siderophores for infection imaging |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 1 |
Určeno pro: | Magisterské studium |
Projekt: | Radiolabelled peptides for cancer imaging |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 1 |
Určeno pro: | Magisterské studium |